SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001021771-21-000002
Filing Date
2021-01-06
Accepted
2021-01-06 16:58:43
Documents
5
Period of Report
2021-01-05
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K DATED JANUARY 5, 2021 RE: LETTER TO SHAREHOLDERS form8kdtd01052021.htm 8-K 16429
2 PRESS RELEASE DATED JANUARY 5, 2021 ex99_1.htm EX-99.1 737
3 biopressrelease_1.jpg GRAPHIC 932816
4 biopressrelease_2.jpg GRAPHIC 993377
5 biopressrelease_3.jpg GRAPHIC 736367
  Complete submission text file 0001021771-21-000002.txt   3684264
Mailing Address 40 MARCUS DRIVE MELVILLE NY 11747
Business Address 40 MARCUS DRIVE MELVILLE NY 11747 (631) 760-8100
BioRestorative Therapies, Inc. (Filer) CIK: 0001505497 (see all company filings)

IRS No.: 911835664 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37603 | Film No.: 21511415
SIC: 8090 Services-Misc Health & Allied Services, NEC